Ipca Labs.

IPCALAB05 Mar 2024
Pharmaceuticals
-12.20 (-1.02%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Ipca Labs.
Ipca Labs.
Pharmaceuticals
IPCALAB05 Mar 2024
-12.20 (-1.02%)

Ipca Labs. - Share Price & Details

Lowest Today
1186.75
Highest Today
1225
Today’s Open
1225
Prev. Close
1201
52 Week High
1264
52 Week Low
670
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
48.09%
Upper Circuit
Lower Circuit
P/E TTM
55.35
P/B Ratio
4.91
Traded Value(Cr)
0.00
EPS TTM
21.7
Book value
Dividend
0.33%

Price Performance

0.00 %
1 Wk
0.00 %
1 M
8.20 %
3 M
48.09 %
1 Y
7.29 %
YTD

Traded Volume Movement

Technical Details

Support 3
1158
Support 2
1172
Support 1
1181
Pivot Point :
1194
Resistance 1
1203
Resistance 2
1217
Resistance 3
1225

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Ipca Laboratories Ltd
₹1,188.80(-12.20/-1.02%)
1,188.80-12.2030,469.8848.0955.354.91
Bliss GVS Pharma Ltd
₹117.85(-4.75/-3.87%)
117.85-4.751,283.5168.8518.801.31
Astrazeneca Pharma India Ltd
₹5,400.00(-53.80/-0.99%)
5,400.00-53.8013,634.5068.6385.4820.82
Cipla Ltd
₹1,462.30(-8.95/-0.61%)
1,462.30-8.95118,782.7765.0336.124.59
Abbott India Ltd
₹27,456.75(-136.70/-0.50%)
27,456.75-136.7058,636.0824.0951.1818.86
Amrutanjan Health Care Ltd
₹680.70(+14.90/2.24%)
680.70+14.901,946.187.6044.217.43

About Ipca Laboratories Ltd

Ipca Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 30469.88 crores. It has reported a sales of Rs. 1506.83 crores and a net profit of Rs. 136.94 crores for the quarter ended December 2018. The company management includes Premchand Godha, Premchand Godha,A K Jain,Pranay Godha,Prashant Godha,Anand T Kusre,Manisha Premnath,Kamal Kishore Seth,Narendra Mairpady,Harish P Kamath (Ipca Laboratories Ltd) among others.
Chairman
Premchand Godha
Registered office
48 Kandivli Industrial Estate,Kandivli (West),Mumbai,Maharashtra,400067
FAX :91-22-28686613
Background
Incorporation Year1949
Face Value₹1
Market Lot1

Latest News

Sensex falls on muted global cues, but analysts see no threat to Nifty
The benchmark Sensex and Nifty 50 indices started trading on March 5 on a negative note following subdued global cues. However, analysts believe that there is no reversal in trend as long as the Nifty sustained the 22,000-mark. Sensex and Nifty shed 0.2 percent each in early trade to 73,707 and 22,354. Broader markets also declined with Nifty Midcap 100 and Nifty Smallcap 100 indices down up.
05 Mar 2024 | 10:28 AM
Sensex falls on muted global cues, but analysts see no threat till Nifty
The benchmark Sensex and Nifty 50 indices started trading on March 5 on a negative note following subdued global cues. However, analysts believe that there is no reversal in trend as long as the Nifty sustained the 22,000-mark. Sensex and Nifty shed 0.2 percent each in early trade to 73,707 and 22,354. Broader markets also declined with Nifty Midcap 100 and Nifty Smallcap 100 indices down up.
05 Mar 2024 | 10:28 AM
Buy or sell: Vaishali Parekh recommends three stocks to buy today
Buy or sell stocks: After showing a sharp upside breakout on 1st March 2024, the Indian stock market continued with the choppy movement for the second consecutive session on Monday. However, key benchmark indices of Dalal Street managed to end higher in the first session of this week. The Nifty 50 index climbed to an all-time high of 22,440 and ended 27 points higher at 22,405 level.
05 Mar 2024 | 09:59 AM
Hot Stocks | JK Lakshmi Cement, Motherson Sumi Wiring, JTEKT India & more
March 2024 began with the Nifty reaching a fresh record high of 22,440. The index found support on the upward sloping trendline adjoining the swing lows of January 24 and February 14 and broke out from the ascending triangle pattern on the weekly chart, indicating continuation of an uptrend. The Nifty has been forming higher tops and higher bottoms on the monthly charts.
05 Mar 2024 | 09:42 AM
Trade Spotlight | How to trade in Piramal Enterprises, BHEL, KEI Industries
The Nifty is likely to face an immediate hurdle at 22,500 in the coming session, given its sustained upward sloping resistance trendline adjoining previous record highs and continuation of higher-highs, higher-lows, but with some volatility and consolidation considering the formation of a Doji candlestick pattern at the top in the previous session. Immediate support is placed at the 22,200 level.
05 Mar 2024 | 09:34 AM

Is Ipca Labs a government-run institution?

No, IPCA Laboratories is not a government-run organization. It is a privately-owned pharmaceutical company based in India. IPCA Laboratories was founded in 1949 and has since grown to become one of the leading pharmaceutical companies in India.

Who is Ipca Labs’ owner?

IPCA Laboratories is a publicly-traded company and its ownership is spread among its shareholders. The Promoter of IPCA Labs is Mr. Premchand Godha and his family.

How well is Ipca Labs doing?

IPCA Laboratories operates in the pharmaceutical industry and has a diverse product portfolio that includes medicines for various therapeutic segments, including antimalarials, anti-bacterial, pain management, and cardiovascular drugs. Ipca Labs’ consolidated revenue has gone from Rs. 3773.18 crores in March 2019 to  Rs. 5,829.79 crores on 31 March 2022. The net profit has gone from Rs. 443.03 crores to Rs. 910.95 crores in the same period. Ipca Labs stock has given a positive return of 10.05% over the past three years and a negative return of -18.57% over the past one year.

What are the latest results of Ipca Labs?

The last fiscal result of Ipca Labs was declared in March 2022 and they reported a consolidated revenue of INR 5,829.79 crore and net profit of Rs. 910.95 crores.

What are the potential catalysts that positively impact the stock price of Ipca lab?

Some potential catalysts that may positively affect IPCA Laboratories' stock price could include: Strong financial results Expansion in new markets Launch of new products Regulatory approvals Industry trends
Click here to see your activities